Codeine cold and flu drugs upschedule not economically sensible: ASMI

The interim decision to upschedule codeine-containing cold and flu medicines to Schedule 4 does not make public health or economic sense, the Australian Self Medication Industry says. It says new figures reveal that upscheduling codeine-containing cold and flu medicines would cost the Australian economy $257 million annually. Costs borne by government due to increased doctor